JBJS - 2026-10-09 - Journal Article
Cervical Disc Arthroplasty: Evolution, Evidence, and Future Directions in Motion-Preservation Surgery.
Kim MT, Lee S, Goh GS, Riew KD
Topics
Key Takeaway
CDA achieves comparable clinical outcomes to ACDF at 1-2 levels with a modest but statistically present reduction in adjacent-segment pathology, though absolute risk reduction at long-term follow-up remains small and heterogeneous across trials.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This narrative review synthesizes the clinical evidence for CDA versus ACDF across 1-level, 2-level, and expanded indications including multilevel (≥3-level) and hybrid constructs. CDA demonstrates equivalent functional outcomes to ACDF with lower adjacent-segment pathology rates, but absolute risk reduction is modest and methodological heterogeneity across IDE trials limits definitive conclusions. The authors identify standardized failure reporting and evidence-based revision algorithms as critical unmet needs as CDA utilization expands.
Key Limitation
The narrative review format without meta-analytic pooling means the stated adjacent-segment pathology advantage for CDA cannot be quantified or statistically validated against the existing RCT evidence showing equivalence.
Original Abstract
➢ Cervical disc arthroplasty (CDA) provides clinical outcomes comparable with those of anterior cervical discectomy and fusion (ACDF) for 1-level and 2-level cervical degenerative disc disease (DDD), with durable long-term motion preservation.➢ Although CDA is associated with lower rates of adjacent-segment pathology compared with ACDF, the absolute risk reduction at longer follow-up is modest and methodological heterogeneity across trials limits definitive conclusions.➢ Expanded indications including multilevel (≥3-level) CDA, hybrid constructs, and other situations that were previously considered contraindicated during U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) trials have shown promising short-term to intermediate-term results in more recent studies.➢ As CDA utilization increases, standardized failure reporting and the development of evidence-based revision algorithms are critical to optimize long-term outcomes.